BI Yingxin, LIU Xianjun, MENG Xianglong, et al. Protective Effect of EGCG on Hydrogen Peroxide-induced Apoptosis of Human Cardiomyocyte via Regulating miR-16-5p/AOC1 Axis[J]. Science and Technology of Food Industry, 2022, 43(7): 376−383. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021080256.
Citation: BI Yingxin, LIU Xianjun, MENG Xianglong, et al. Protective Effect of EGCG on Hydrogen Peroxide-induced Apoptosis of Human Cardiomyocyte via Regulating miR-16-5p/AOC1 Axis[J]. Science and Technology of Food Industry, 2022, 43(7): 376−383. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021080256.

Protective Effect of EGCG on Hydrogen Peroxide-induced Apoptosis of Human Cardiomyocyte via Regulating miR-16-5p/AOC1 Axis

More Information
  • Received Date: August 24, 2021
  • Available Online: February 10, 2022
  • Objective: To explore the molecular mechanism driving the tea polyphenol epigallocatechin-3-gallate (EGCG)-exerted protective effect on hydrogen peroxide (H2O2)-induced cell apoptosis of human cardiomyocyte HCM cell lines. Methods: HCM cells were stimulated with H2O2 to establish a vitro apoptosis model; the caspase-3 assay was used to assess the cell apoptosis of HCM cells; the CCK-8 assay was used to perform the cytotoxicity experiment; qPCR was used to detect the levels of AOC1 mRNA and miR-16-5p; Western blot was used to detect the protein level of AOC1; cells transfection was conducted to regulate the expression levels of AOC1 and miR-16-5p in HCM cells; TargetScan was used to predict the binding relationship and site between AOC1 mRNA 3’UTR and miR-16-5p, which was verified by the double luciferase reporter gene assay. Results: EGCG could significantly inhibit H2O2-induced apoptosis of HCM cells (P<0.05). In apoptotic cells, the expression of AOC1 was significantly decreased, and EGCG could significantly up-regulate the expression of AOC1, while knocking down AOC1 could significantly reverse the inhibition of EGCG on apoptosis (P<0.05). Meanwhile, the expression of miR-16-5p was significantly increased in apoptotic cells, and EGCG could significantly inhibit the expression of miR-16-5p, while up-regulation of miR-16-5p significantly reversed the inhibition of EGCG on apoptosis (P<0.05). Upregulation of miR-16-5p significantly reversed the promotion of AOC1 expression by EGCG in apoptotic cells. Finally, miR-16-5p can target inhibit the expression of AOC1, while over expression of AOC1 significantly reversed miR-16-5p-induced apoptosis of HCM cells. Conclusion: EGCG protected H2O2-induced apoptosis of HCM cells by regulating the miR-16-5p/AOC1 axis, which proposes AOC1 as a potential novel therapeutic target pro-tection against cardiomyocyte injury.
  • [1]
    ALMATROODI S A, ALMATROUDI A, KHAN A A, et al. Potential therapeutic targets of epigallocatechin gallate (EGCG), the most abundant catechin in green tea, and its role in the therapy of various types of cancer[J]. Molecules,2020,25(14):3146. doi: 10.3390/molecules25143146
    [2]
    NAGATA S. Apoptosis and clearance of apoptotic cells[J]. Annu Rev Immunol,2018,36:489−517. doi: 10.1146/annurev-immunol-042617-053010
    [3]
    O'BRIEN J, HAYDER H, ZAYED Y, et al. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation[J]. Front Endocrinol (Lausanne),2018,9:402. doi: 10.3389/fendo.2018.00402
    [4]
    RUPAIMOOLE R, SLACK F J. MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases[J]. Nat Rev Drug Discov,2017,16(3):203−222. doi: 10.1038/nrd.2016.246
    [5]
    ARDEKANI A M, NAEINI M M. The role of microRNAs in human diseases[J]. Avicenna J Med Biotechnol,2010,2(4):161−79.
    [6]
    LIU H, WANG L, LI F, et al. The synergistic protection of EGCG and quercetin against streptozotocin (STZ)-induced NIT-1 pancreatic β cell damage via upregulation of BCL-2 expression by miR-16-5p[J]. J Nutr Biochem,2021,96:108748. doi: 10.1016/j.jnutbio.2021.108748
    [7]
    KIRSCHNER K M, BRAUN J F, JACOBI C L, et al. Amine oxidase copper-containing 1 (AOC1) is a downstream target gene of the Wilms tumor protein, WT1, during kidney development[J]. J Biol Chem,2014,289(35):24452−24462. doi: 10.1074/jbc.M114.564336
    [8]
    SUN W Y, CHOI J, CHA Y J, et al. Evaluation of the expression of amine oxidase proteins in breast cancer[J]. Int J Mol Sci,2017,18(12):2775. doi: 10.3390/ijms18122775
    [9]
    LI J, YUAN J. Caspases in apoptosis and beyond[J]. Oncogene,2008,27(48):6194−6206. doi: 10.1038/onc.2008.297
    [10]
    MCCOMB S, CHAN P K, GUINOT A, et al. Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7[J]. Sci Adv,2019,5(7):eaau9433. doi: 10.1126/sciadv.aau9433
    [11]
    BELL R, ROBLES-HARRIS M A, ANDERSON M, et al. Inhibition of apoptosis exacerbates fatigue-damage tendon injuries in an in vivo rat model[J]. Eur Cell Mater,2018,36:44−56. doi: 10.22203/eCM.v036a04
    [12]
    MARQUES-ALEIXO I, SANTOS-ALVES E, OLIVEIRA P J, et al. The beneficial role of exercise in mitigating doxorubicin-induced mitochondrionopathy[J]. Biochim Biophys Acta Rev Cancer,2018,1869(2):189−199. doi: 10.1016/j.bbcan.2018.01.002
    [13]
    DU S P, ROEDERER G, DUFOUR R. Myotoxicity of statins: Mechanism of action[J]. Pharmacol Ther,2017,175:1−16. doi: 10.1016/j.pharmthera.2017.02.029
    [14]
    NEGRI A, NAPONELLI V, RIZZI F, et al. Molecular targets of epigallocatechin-gallate (EGCG): A special focus on signal transduction and cancer[J]. Nutrients,2018,10(12):1936. doi: 10.3390/nu10121936
    [15]
    ZHANG X, WANG J, HU J M, et al. Synthesis and biological testing of novel glucosylated epigallocatechin gallate (EGCG) derivatives[J]. Molecules,2016,21(5):620. doi: 10.3390/molecules21050620
    [16]
    LORENZ M, RAUHUT F, HOFER C, et al. Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG)[J]. Scientific Reports,2017,7:2279. doi: 10.1038/s41598-017-02384-x
    [17]
    KHIEWKAMROP P, PHUNSOMBOON P, RICHERT L, et al. Epistructured catechins, EGCG and EC facilitate apoptosis induction through targeting de novo lipogenesis pathway in HepG2 cells[J]. Cancer Cell Int,2018,18:46. doi: 10.1186/s12935-018-0539-6
    [18]
    HUANG C Y, HAN Z, LI X, et al. Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer[J]. Oncol Lett,2017,14(3):3623−3627. doi: 10.3892/ol.2017.6641
    [19]
    PONATH E, SCHNABL S, HILGARTH M, et al. Green tea extract EGCG induces apoptosis in CLL cells and overcomes the supportive effect of primary bone marrow stromal cells through the regulation of PI3K/Akt cascade and proteasome activity[J]. Blood,2012,120(21):3916. doi: 10.1182/blood.V120.21.3916.3916
    [20]
    TANG Y, ZHAO D Y, ELLIOTT S, et al. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression[J]. Int J Oncol,2007,31(4):705−711.
    [21]
    SHENG R, GU Z L, XIE M L, et al. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats[J]. Acta Pharmacol Sin,2007,28(2):191−201. doi: 10.1111/j.1745-7254.2007.00495.x
    [22]
    KHURANA S, HOLLINGSWORTH A, PICHE M, et al. Antiapoptotic actions of methyl gallate on neonatal rat cardiac myocytes exposed to H2O2[J]. Oxid Med Cell Longev,2014,2014:657512.
    [23]
    XU F, XU Y, XIONG J H, et al. AOC1 contributes to tumor progression by promoting the AKT and EMT pathways in gastric cancer[J]. Cancer Manag Res,2020,12:1789−1798. doi: 10.2147/CMAR.S225229
    [24]
    TONINELLO A, PIETRANGELI P, DE M U, et al. Amine oxidases in apoptosis and cancer[J]. Biochim Biophys Acta,2006,1765(1):1−13.
    [25]
    LIU F, OU W, TANG W, et al. Increased AOC1 expression promotes cancer progression in colorectal cancer[J]. Front Oncol,2021,11:657210. doi: 10.3389/fonc.2021.657210
    [26]
    CHEN H, ZHANG Z, FENG D. Prediction and interpretation of miRNA-disease associations based on miRNA target genes using canonical correlation analysis[J]. BMC Bioinformatics,2019,20(1):404. doi: 10.1186/s12859-019-2998-8
    [27]
    KUOSMANEN S M, HARTIKAINEN J, HIPPELÄINEN M, et al. MicroRNA profiling of pericardial fluid samples from patients with heart failure[J]. PLoS One,2015,10(3):e0119646. doi: 10.1371/journal.pone.0119646
    [28]
    WAKABAYASHI I, EGUCHI R, SOTODA Y, et al. Blood levels of microRNAs associated with ischemic heart disease differ between Austrians and Japanese: A pilot study[J]. Sci Rep,2020,10(1):13628. doi: 10.1038/s41598-020-69332-0
    [29]
    CAO Z, LIU J, ZHAO Z, et al. miR-16-5p regulates PTPN4 and affects cardiomyocyte apoptosis and autophagy induced by hypoxia/reoxygenation[J]. Evid Based Complement Alternat Med,2021,2021:5599031.
    [30]
    安玉成, 仝识非, 王端, 等. MiR-16-5p靶向TXNIP调控脂多糖诱导的心肌细胞的氧化应激和凋亡[J]. 中国生物化学与分子生物学报,2020,36(8):934−944. [AN Y C, TONG S F, WANG D, et al. MiR-15-5p targets TXNIP to regulate LPS-induced oxidative stress and apoptisis in cardiomyocytes[J]. Chinese Journal of Biochemistry and Molecular Biology,2020,36(8):934−944.
  • Cited by

    Periodical cited type(4)

    1. 关玉婷,温思萌,冯雪,白云鹏,陈瑞瑞,沈晓勇,冯佳宁,常世敏,程鑫颖. 茯苓渣多糖组成分析及体外抗癌、免疫活性研究. 食品工业科技. 2022(21): 381-387 . 本站查看
    2. 李霞,刘承鑫,黄艳,莫观兰,关媛. 碱提西番莲叶多糖的分离、鉴定及生物活性. 食品与机械. 2021(03): 137-143 .
    3. 钱艳艳,王丽,文春南,周艳,李晓,张丽先,周贤宇,麻兵继. 鲜地黄低聚糖纯化及其理化特性和抗氧化活性研究. 天然产物研究与开发. 2021(09): 1470-1477 .
    4. 王峙力,王鑫,韩烨,谢越,马永强. 甜玉米芯硒多糖的制备及其对淀粉酶抑制作用. 包装工程. 2021(21): 33-41 .

    Other cited types(4)

Catalog

    Article Metrics

    Article views (196) PDF downloads (28) Cited by(8)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return